Physician profile
Scott Kochenower
NPI 1174848790
$9,117.46
in general payments reported to CMS, 2019-2025
21 companies · $589 in 2025
The $589 reported for 2025 was more than what a typical Foot & Ankle Surgery provider received nationally (typical 2025 total: $424).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $390 · 2020: $3,489 · 2021: $1,451 · 2022: $561 · 2023: $2,088 · 2024: $549 · 2025: $589.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,814 · Travel and Lodging: $1,412.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,813.50 |
| Travel and Lodging | $1,412.44 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Treace Medical Concepts, INC. | $3,607.80 | 2020-2025 | |
| Arthrex, INC. | $2,249.24 | 2020 | |
| Pylant Medical | $1,674.19 | 2019-2025 | |
| Trice Medical, INC. | $353.40 | 2020-2023 | |
| Smith+Nephew, INC. | $300.73 | 2019-2025 | Stravix, Grafix, Oasis |
| Stryker Corporation | $201.54 | 2023-2025 | Infinity Adaptis, Augment Injectable, Easyfuse |
| Organogenesis INC. | $193.12 | 2019-2023 | Puraply Antimicrobial |
| Depuy Synthes Sales INC. | $156.69 | 2022 | |
| Zimmer Biomet Holdings, INC. | $117.00 | 2019 | |
| Abbvie INC. | $39.92 | 2022 | |
| Tactile Systems Technology INC | $37.72 | 2024 | Flexitouch Plus, Entre Plus |
| Bioventus LLC | $35.32 | 2019-2022 | |
| Zyla Life Sciences, INC. | $22.09 | 2019 | |
| Restor3d, INC. | $20.85 | 2023 | |
| Pacira Pharmaceuticals Incorporated | $20.63 | 2019 |
Show all 21 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Averitas Pharma INC. | $18.01 | 2024 | Qutenza |
| Orthofix Medical, INC. | $17.84 | 2022 | |
| Solventum Corporation | $13.64 | 2024 | Prevena, V.A.C. Veraflo |
| Merck Sharp & Dohme LLC | $13.39 | 2019 | |
| Osiris Therapeutics INC. | $12.60 | 2019 | |
| Pacira Therapeutics, INC. | $11.74 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Scott Kochenower listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.